Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis
2019
Acute myeloid leukemia (AML) represents a heterogeneous group of disorders characterized by the rapid expansion of immature myeloid cells (blasts) in the bone marrow (BM). There is wide disease heterogeneity, and patient risk-stratification principally relies on cytogenetic-molecular data.[1][1] A
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
8
Citations
NaN
KQI